Ticker

New Human Health Subsidiary to Advance Development of Innovative Biomaterial Technologies and Potential New Products for Human and Animal Health MINNEAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) ("PetVivo" or the "Company"), an emerging biomedical device company focused on the commercialization and development of innovative medical devices and therapeutics, announced today that its…

PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript

MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported financial and operational results for the first quarter of its fiscal year ended June 30, 2026.

MINNEAPOLIS, MN, US, Aug. 07, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), an emerging biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, August 14, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal first quarter ended June 30, 2026.

Agreement Resolves All Outstanding Matters and Completes Transition of PrecisePRP ® Product Line MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) working in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp and PetVivo AI, Inc. (collectively "PetVivo" or the “Company”), an emerging biomedical device company focused on the…